Development of Fully Human Antibodies Targeting SIRPα and PLA2G7 for Cancer Therapy.
Saved in:
| Title: | Development of Fully Human Antibodies Targeting SIRPα and PLA2G7 for Cancer Therapy. |
|---|---|
| Authors: | Shin S; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA., Baek DS; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.; GLPG US, 1401 Forbes Avenue, Pittsburgh, PA 15219, USA., Mellors JW; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.; GLPG US, 1401 Forbes Avenue, Pittsburgh, PA 15219, USA., Dimitrov DS; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.; GLPG US, 1401 Forbes Avenue, Pittsburgh, PA 15219, USA., Li W; Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA. |
| Source: | Antibodies (Basel, Switzerland) [Antibodies (Basel)] 2025 Mar 03; Vol. 14 (1). Date of Electronic Publication: 2025 Mar 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101587489 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4468 (Electronic) Linking ISSN: 20734468 NLM ISO Abbreviation: Antibodies (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2073-4468 |
|---|---|
| DOI: | 10.3390/antib14010021 |
